Navy General Hospital, Beijing

Burden-Evaluated Atrial Fibrillation Progession and ThromboEmbolim Study BEAT-AF TE Study

Role: lead

177Lu-CTR-FAPI for the Treatment of Thyroid Cancer

Role: collaborator

A Randomized Trial of Six-Channel RF Ablation System for Renal Denervation in Uncontrolled Hypertension and Chronic Kidney Disease

Role: collaborator

Cohort Observing Mechanisms, Progression and Sequelae of Valvular Heart Disease

Role: collaborator

G-Pola-GemOx in Refractory/Relapsed Aggressive B-Cell Lymphoma

Role: lead

The Combination of ATRA and Eltrombopag as the Treatment of Steroid-resistant/Relapse ITP Based on MSC-C5b-9

Role: collaborator

Pola-ZR2P in Previously Untreated DLBCL

Role: lead

G-Pola-ZLP in Diffuse Large B-Cell Lymphoma

Role: lead

Teriflunomide Plus High-dose Dexamethasone as First-line Treatment in Newly Diagnosed Primary Immune Thrombocytopenia

Role: collaborator

Impact of Remimazolam on Prognosis After Bladder Cancer Surgery

Role: collaborator

The Combination of Upadacitinib and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia

Role: collaborator

Iguratimod Plus Low-dose Rituximab vs Low-dose Rituximab in Corticosteroid-resistant or Relapsed ITP

Role: collaborator

Smart Technology Facilitated Patient-centered Care for Patients With Pulmonary Thromboembolism

Role: lead

Smart Technology Facilitated Patient-centered Venous Thromboembolism Management

Role: lead

Study on Cardiac Output Evaluation Based on Wearable Monitoring Data

Role: lead

SIL as Maintenance Therapy in Multiple Myeloma

Role: lead

Azacytidine Plus CAOLD Regimen in Relapsed/Refractory Peripheral T-Cell Lymphomas

Role: lead

VA Conditioning Regimen Allo-HSCT for Elderly Higher-risk MDS

Role: lead

VA as Maintenance Therapy Post Allo-HSCT in MDS and AML

Role: lead

Zanubrutinib and Lenalidomide as Maintenance Therapy in DLBCL

Role: lead